Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1120017
PUBLISHER: IMARC Services Private Limited | PRODUCT CODE: 1120017
COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
The global COVID-19 diagnostics market size reached US$ 94.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 32.1 Billion by 2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, sample type, test type, mode and end use.
Breakup by Product Type:
- Reagents and Kits
- Instruments
- Others
Breakup by Sample Type:
- Nasopharyngeal Swabs
- Oropharyngeal Swabs
- Nasal Swabs
- Blood
- Others
Breakup by Test Type:
- Molecular (RT-PCR) Testing
- Antigen-based Testing
- Antibody (Serology) Testing
- Others
Breakup by Mode:
- Point-of-Care (PoC)
- Non-Point-of-Care (Non-PoC)
Breakup by End Use:
- Laboratories
- Hospitals
- Diagnostic Centers and Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global COVID-19 diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the sample type?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the mode?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global COVID-19 diagnostics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR0922A127_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global COVID-19 Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Reagents and Kits
- 6.1.1 Market Trends and Forecast
- 6.2 Instruments
- 6.2.1 Market Trends and Forecast
- 6.3 Others
- 6.3.1 Market Trends and Forecast
7 Market Breakup by Sample Type
- 7.1 Nasopharyngeal Swabs
- 7.1.1 Market Trends and Forecast
- 7.2 Oropharyngeal Swabs
- 7.2.1 Market Trends and Forecast
- 7.3 Nasal Swabs
- 7.3.1 Market Trends and Forecast
- 7.4 Blood
- 7.4.1 Market Trends and Forecast
- 7.5 Others
- 7.5.1 Market Trends and Forecast
8 Market Breakup by Test Type
- 8.1 Molecular (RT-PCR) Testing
- 8.1.1 Market Trends and Forecast
- 8.2 Antigen-based Testing
- 8.2.1 Market Trends and Forecast
- 8.3 Antibody (Serology) Testing
- 8.3.1 Market Trends and Forecast
- 8.4 Others
- 8.4.1 Market Trends and Forecast
9 Market Breakup by Mode
- 9.1 Point-of-Care (PoC)
- 9.1.1 Market Trends and Forecast
- 9.2 Non-Point-of-Care (Non-PoC)
- 9.2.1 Market Trends and Forecast
10 Market Breakup by End Use
- 10.1 Laboratories
- 10.1.1 Market Trends and Forecast
- 10.2 Hospitals
- 10.2.1 Market Trends and Forecast
- 10.3 Diagnostic Centers and Clinics
- 10.3.1 Market Trends and Forecast
- 10.4 Others
- 10.4.1 Market Trends and Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends and Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends and Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends and Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends and Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends and Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends and Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends and Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends and Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends and Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends and Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends and Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends and Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends and Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends and Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends and Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends and Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends and Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends and Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends and Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends and Forecast
- 11.5.2 Market Breakup by Country
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Abbott Laboratories
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Becton Dickinson and Company
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 bioMerieux SA
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Bio-Rad Laboratories
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Danaher Corporation
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.7 Luminex Corporation
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 PerkinElmer Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Quest Diagnostics Incorporated
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Robert Bosch GmbH
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.11 Seegene Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.12 Siemens Aktiengesellschaft
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.13 Thermo Fisher Scientific Inc.
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.13.3 Financials
- 16.3.13.4 SWOT Analysis
- 16.3.1 Abbott Laboratories
Product Code: SR0922A127_Report
List of Figures
- Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2021-2027
- Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2021
- Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2021
- Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2021
- Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2021
- Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2021
- Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2021
- Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2021-2027
- Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2021-2027
- Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2021-2027
- Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2021-2027
- Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2021-2027
- Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2021-2027
- Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2021-2027
- Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2021-2027
- Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2021-2027
- Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2021-2027
- Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million US$), 2021-2027
- Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2021-2027
- Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million US$), 2021-2027
- Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million US$), 2021-2027
- Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2021-2027
- Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2021-2027
- Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2021-2027
- Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2021-2027
- Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
- Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2021
- Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
- Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
- Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2021 and 2027
- Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
- Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2022-2027
- Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
- Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2022-2027
- Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2022-2027
- Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
- Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
- Table 9: Global: COVID-19 Diagnostics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.